DYNE THERAPEUTICS Trademark
Trademark Overview
On Tuesday, August 8, 2023, a trademark application was filed for DYNE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the DYNE THERAPEUTICS trademark a serial number of 98121697. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 23, 2024. This trademark is owned by Dyne Therapeutics, Inc.. The DYNE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and development of pharmaceuticals for treating muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders; research and development services relating to the treatment of muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders
General Information
| Serial Number | 98121697 |
| Word Mark | DYNE THERAPEUTICS |
| Filing Date | Tuesday, August 8, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, July 23, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 28, 2024 |
Trademark Statements
| Description of Mark | The mark consists of a representation of an antibody with the left side in black and the right side in white with a black circle at the bottom of the antibody design and the words "DYNE THERAPEUTICS" to the right of the antibody design. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Research and development of pharmaceuticals for treating muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders; research and development services relating to the treatment of muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 6, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Dyne Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
| Party Name | Dyne Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
Trademark Events
| Event Date | Event Description |
| Friday, August 11, 2023 | NEW APPLICATION ENTERED |
| Wednesday, September 6, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 7, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, February 14, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, February 14, 2024 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Tuesday, February 27, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, February 27, 2024 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Tuesday, April 9, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, April 24, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 8, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 23, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 28, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 28, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
